Tanaka T - Search Results

1

Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.

Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H. Fujita H, et al. Among authors: tanaka t, tanaka y. J Surg Oncol. 2005 Jun 15;90(4):209-19. doi: 10.1002/jso.20259. J Surg Oncol. 2005. PMID: 15906363 Clinical Trial.

2

Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.

Fujii T, Sudo T, Sueyoshi S, Tanaka T, Fujita H, Shirouzu K, Ban S, Toyonaga A, Kato S, Yamana H. Fujii T, et al. Among authors: tanaka t. Int J Oncol. 2002 Dec;21(6):1181-7. Int J Oncol. 2002. PMID: 12429966

3

Intraarterial cellular immunotherapy for patients with inoperable liver metastases of esophageal cancer.

Toh U, Sudo T, Kido K, Tanaka T, Sueyoshi S, Fujita H, Hiraki M, Horiuchi H, Shirouzu K, Yamana H. Toh U, et al. Among authors: tanaka t. Gan To Kagaku Ryoho. 2002 Nov;29(12):2152-6. Gan To Kagaku Ryoho. 2002. PMID: 12484026

4

Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer.

Toh U, Sudo T, Kido K, Matono S, Sasahara H, Mine T, Tanaka T, Sueyoshi S, Fujita H, Shirouzu K, Yamana H. Toh U, et al. Among authors: tanaka t. Int J Clin Oncol. 2002 Dec;7(6):372-5. doi: 10.1007/s101470200058. Int J Clin Oncol. 2002. PMID: 12494255

5

Three-field dissection for squamous cell carcinoma in the thoracic esophagus.

Fujita H, Sueyoshi S, Tanaka T, Shirouzu K. Fujita H, et al. Among authors: tanaka t. Ann Thorac Cardiovasc Surg. 2002 Dec;8(6):328-35. Ann Thorac Cardiovasc Surg. 2002. PMID: 12517291

6

Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy.

Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, Sasahara H, Sudo T, Matono S, Yamana H, Shirouzu K. Fujita H, et al. Among authors: tanaka t. World J Surg. 2003 May;27(5):571-9. doi: 10.1007/s00268-003-6913-z. Epub 2003 Apr 28. World J Surg. 2003. PMID: 12715226

7

Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective study.

Heroor A, Fujita H, Sueyoshi S, Tanaka T, Toh U, Mine T, Sasahara H, Sudo T, Matono S, Yamana H, Shirouzu K. Heroor A, et al. Among authors: tanaka t. Dig Surg. 2003;20(3):229-35; discussion 236-7. doi: 10.1159/000070390. Dig Surg. 2003. PMID: 12759503

8

[Chemoradiotherapy for esophageal cancer].

Fujita H, Sueyoshi S, Tanaka T, Sasahara H, Matono S, Yamana H, Shirouzu K, Suzuki G, Hayabuchi N. Fujita H, et al. Among authors: tanaka t. Gan To Kagaku Ryoho. 2003 Jul;30(7):937-43. Gan To Kagaku Ryoho. 2003. PMID: 12894707 Review. Japanese.

9

Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.

Matono S, Tanaka T, Sueyoshi S, Yamana H, Fujita H, Shirouzu K. Matono S, et al. Among authors: tanaka t. Int J Oncol. 2003 Nov;23(5):1309-15. Int J Oncol. 2003. PMID: 14532970

10

[Preliminary evaluation of chemotherapy with docetaxel, 5-FU, CDDP for recurrent esophageal cancer--a pilot study].

Tanaka T, Sueyoshi S, Sasahara H, Matono S, Yamana H, Shirouzu K, Fujita H. Tanaka T, et al. Gan To Kagaku Ryoho. 2003 Nov;30(12):1955-8. Gan To Kagaku Ryoho. 2003. PMID: 14650966 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,382 results

Search Page

Filters